Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...
The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.
Experts from NYU Langone Heart will present the latest advancements in cardiovascular science and clinical care at the 2024 American Heart Association's Scientific Sessions, held from November 16 to ...
CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as ...
MedPage Today on MSN17h
JAK Inhibitor Succeeds in Giant Cell Arteritis TrialWASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation ...
Discover the results of a groundbreaking phase 3 trial presented at ACR 2024, showing upadacitinib's efficacy in managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback